Keywords: Valeant, Brazil, Branded generics, OTC, Acquisition
Valeant to acquire pharmaceutical company in Brazil for $56 million
Article | 22 April 2010
California, USA-based Valeant Pharmaceuticals International says that it has signed a binding agreement to acquire an unnamed, privately-held pharmaceutical company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
